Liver Diseases  >>  Aptivus (tipranavir)  >>  Phase 1
Welcome,         Profile    Billing    Logout  

2 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
Aptivus (tipranavir) / Boehringer Ingelheim
NCT02249442: Study to Determine the Pharmacokinetics on TPV/r in Subjects With Mild and Moderate Hepatic Insufficiency

Completed
1
24
Canada
Tipranavir (TPV), Ritonavir (r)
Boehringer Ingelheim
Hepatic Insufficiency
06/04
 
NCT02259855: Pharmacokinetics (PK) of Tipranavir/Ritonavir, Ribavirin, Pegylated Interferon (Peg INF) in Hepatitis C (HCV) Subjects With Mild Hepatic Impairment and in HCV, Hepatitis B (HBV), Hepatitis D Infected Subjects or Alcoholic Cirrhosis With Moderate Hepatic Impairment

Completed
1
36
Europe, RoW
Tipranavir, Ritonavir, Pegylated interferon, Ribavirin
Boehringer Ingelheim
Hepatic Insufficiency
10/08
 

Download Options